CoChat
Sign Up
Cited by 247

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Somatic LKB1 Mutations Promote Cervical Cancer Progression

Wingo, Shana N., Gallardo, Teresa D., Akbay, Esra A., Liang, Mei-Chi, Contreras, Cristina M., Boren, Todd, Shimamura, Takeshi, Miller, David S., Sharpless, Norman E., Bardeesy, Nabeel, Kwiatkowski, David J., Schorge, John O., Wong, Kwok-Kin, Castrillon, Diego H.·2009·PLoS ONE
DOI 10.1371/journal.pone.0005137PMC PMC2660434
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0005137

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Somatic mutations and deletions of LKB1 in cervical tumors. (A) Representative chromatograms of primary tumors. (B) C4I cell line. Lower panels, control DNA samples from each patient (for C4I, human peripheral leukocyte DNA). Wild-type sequences are shown below. Chromatograms represent forward strand except case #41 where reverse complement is shown to more clearly illustrate the deletion. Mutations are heterozygous except where indicated. (C) LKB1 deletions in primary cervical tumors by MLPA. Bars = relative signal intensity per probe. Sixteen probes (black) correspond to LKB1 locus on chromosome 19. Probe identifiers shown below. Probes 0.9M5′ and 0.6M5′ are ∼900 and 600 kb 5′ of locus (telomeric), while 10M3′ is ∼10000 kb 3′ (centromeric); remaining 13 probes correspond to LKB1 noncoding/coding exons. White bars correspond to randomly selected probes from other chromosomes.
Figure 1 Somatic mutations and deletions of LKB1 in cervical tumors. (A) Representative chromatograms of primary tumors. (B) C4I cell line. Lower panels, control DNA samples from each patient (for C4I, human peripheral leukocyte DNA). Wild-type sequences are shown below. Chromatograms represent forward strand except case #41 where reverse complement is shown to more clearly illustrate the deletion. Mutations are heterozygous except where indicated. (C) LKB1 deletions in primary cervical tumors by MLPA. Bars = relative signal intensity per probe. Sixteen probes (black) correspond to LKB1 locus on chromosome 19. Probe identifiers shown below. Probes 0.9M5′ and 0.6M5′ are ∼900 and 600 kb 5′ of locus (telomeric), while 10M3′ is ∼10000 kb 3′ (centromeric); remaining 13 probes correspond to LKB1 noncoding/coding exons. White bars correspond to randomly selected probes from other chromosomes.CC BY · PubMed Central
Figure 2 LKB1 mutations occur in each of the principal histologic subtypes of cervical cancer. (A) Histology of representative cases with LKB1 mutations (SCC = squamous cell carcinoma; Adeno = adenocarcinoma; AdenoSq = adenosquamous carcinoma; MDA = minimal deviation adenocarcinoma). Scale bar = 20 microns. (B) Relative distribution of the three principal histologic subtypes among LKB1-mutant (red) vs. LKB1-wild type (black) cases (totals = 100%) shows that the histologic spectrum is virtually identical in LKB1 null vs. wild-type tumors.
Figure 2 LKB1 mutations occur in each of the principal histologic subtypes of cervical cancer. (A) Histology of representative cases with LKB1 mutations (SCC = squamous cell carcinoma; Adeno = adenocarcinoma; AdenoSq = adenosquamous carcinoma; MDA = minimal deviation adenocarcinoma). Scale bar = 20 microns. (B) Relative distribution of the three principal histologic subtypes among LKB1-mutant (red) vs. LKB1-wild type (black) cases (totals = 100%) shows that the histologic spectrum is virtually identical in LKB1 null vs. wild-type tumors.CC BY · PubMed Central
Figure 3 Homozygous LKB1 deletions occur in majority of cervical cancer cell lines. (A) MLPA; see Figure 1 for probe details. HeLa, MS751, SiHa, and HT3 (and HeLa subclone HeLaS3) contain distinctive homozygous deletions. C4I harbors a monoallelic deletion, as evidenced by contiguous probes with half-intensity signals. (B) Southern analysis of control DNA, above cell lines, C33 (no deletion by MLPA) and HPV16/E6E7-immortalized endocervical cells from a normal patient (Endo = End1/E6E7; ATCC #CRL-2615). (C) Western analysis. LKB1 protein is undetectable in lines harboring homozygous deletions and decreased by ∼50% in C4I, consistent with monoallelic loss.
Figure 3 Homozygous LKB1 deletions occur in majority of cervical cancer cell lines. (A) MLPA; see Figure 1 for probe details. HeLa, MS751, SiHa, and HT3 (and HeLa subclone HeLaS3) contain distinctive homozygous deletions. C4I harbors a monoallelic deletion, as evidenced by contiguous probes with half-intensity signals. (B) Southern analysis of control DNA, above cell lines, C33 (no deletion by MLPA) and HPV16/E6E7-immortalized endocervical cells from a normal patient (Endo = End1/E6E7; ATCC #CRL-2615). (C) Western analysis. LKB1 protein is undetectable in lines harboring homozygous deletions and decreased by ∼50% in C4I, consistent with monoallelic loss.CC BY · PubMed Central
Figure 4 LKB1 deletion breakpoints in cervical cancer cell lines. (A) LKB1 locus (chromosome 19p13.3). (B) 140 kb region (Ensembl50; 1050000–1190000) spanning LKB1 and immediately flanking loci; intervals = 10 kb. (C) Deletion breakpoints for cell lines harboring homozygous deletions. In MS751, deleted sequences are discontinuous as shown, consistent with a more complex rearrangement. Arrows = PCR primers for HeLa specific PCR (400 bp). (D) HeLa specific PCR (400 bp) confirms presence of deletion in HeLaS3. (E) HeLa intragenic LKB1 deletion occurred in vivo. Archival blocks were cored for DNA preparation. Lanes are as follows: (−) control = no template control; tumor = metastatic adrenal deposit; non-tumor = normal adrenal (same tissue block); (+) control = HeLa cell line DNA.
Figure 4 LKB1 deletion breakpoints in cervical cancer cell lines. (A) LKB1 locus (chromosome 19p13.3). (B) 140 kb region (Ensembl50; 1050000–1190000) spanning LKB1 and immediately flanking loci; intervals = 10 kb. (C) Deletion breakpoints for cell lines harboring homozygous deletions. In MS751, deleted sequences are discontinuous as shown, consistent with a more complex rearrangement. Arrows = PCR primers for HeLa specific PCR (400 bp). (D) HeLa specific PCR (400 bp) confirms presence of deletion in HeLaS3. (E) HeLa intragenic LKB1 deletion occurred in vivo. Archival blocks were cored for DNA preparation. Lanes are as follows: (−) control = no template control; tumor = metastatic adrenal deposit; non-tumor = normal adrenal (same tissue block); (+) control = HeLa cell line DNA.CC BY · PubMed Central
Figure 5 Progression-free survival of patients with LKB1-wild type vs. LKB1-mutant tumors. Kaplan-Meier curves show the percentage of patients with disease progression over time. The curves compare patients whose tumors were heterozygous or homozygous for mutations/deletions (LKB1) vs. patients with no mutations/deletions (wt). Patients with >1 follow-up visit were included in the analysis. P value per log-rank test.
Figure 5 Progression-free survival of patients with LKB1-wild type vs. LKB1-mutant tumors. Kaplan-Meier curves show the percentage of patients with disease progression over time. The curves compare patients whose tumors were heterozygous or homozygous for mutations/deletions (LKB1) vs. patients with no mutations/deletions (wt). Patients with >1 follow-up visit were included in the analysis. P value per log-rank test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 29

  1. WM Schoell, 1999, Epidemiology and biology of cervical cancer., Semin Surg Oncol, 16, 203, 10.1002/(SICI)1098-2388(199904/05)16:3<203::AID-SSU2>3.0.CO;2-C · DOI
  2. M Steben, 2007, Human papillomavirus infection: epidemiology and pathophysiology., Gynecol Oncol, 107, S2, 10.1016/j.ygyno.2007.07.067 · DOI
  3. LH Ellenson, 2004, Focus on endometrial and cervical cancer., Cancer Cell, 5, 533, 10.1016/j.ccr.2004.05.029 · DOI
  4. M Arbyn, 2008, Liquid compared with conventional cervical cytology: a systematic review and meta-analysis., Obstet Gynecol, 111, 167, 10.1097/01.AOG.0000296488.85807.b3 · DOI
  5. KL Dall, 2008, Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions., Cancer Res, 68, 8249, 10.1158/0008-5472.CAN-08-1741 · DOI
  6. H zur Hausen, 1976, Condylomata acuminata and human genital cancer., Cancer Res, 36, 794
  7. DR Alessi, 2006, Lkb1-dependent signaling pathways., Annu Rev Biochem, 75, 137, 10.1146/annurev.biochem.75.103004.142702 · DOI
  8. S Matsumoto, 2007, Prevalence and specificity of LKB1 genetic alterations in lung cancers., Oncogene, 26, 5911, 10.1038/sj.onc.1210418 · DOI
  9. CM Contreras, 2008, Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas., Cancer Res, 68, 759, 10.1158/0008-5472.CAN-07-5014 · DOI
  10. S Gurumurthy, 2008, LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis., Cancer Res, 68, 55, 10.1158/0008-5472.CAN-07-3225 · DOI
  11. N Hearle, 2006, Frequency and spectrum of cancers in the Peutz-Jeghers syndrome., Clin Cancer Res, 12, 3209, 10.1158/1078-0432.CCR-06-0083 · DOI
  12. J Boudeau, 2003, Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients., Hum Mutat, 21, 172, 10.1002/humu.9112 · DOI
  13. J Nezu, 1999, Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients., Biochem Biophys Res Commun, 261, 750, 10.1006/bbrc.1999.1047 · DOI
  14. V Launonen, 2000, No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas., Cancer Res, 60, 546
  15. N Bardeesy, 2002, Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation., Nature, 419, 162, 10.1038/nature01045 · DOI
  16. RH Young, 2002, Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis., Histopathology, 41, 185, 10.1046/j.1365-2559.2002.01462.x · DOI
  17. M Tiainen, 1999, Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest., Proc Natl Acad Sci U S A, 96, 9248, 10.1073/pnas.96.16.9248 · DOI
  18. M Esteller, 2000, Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome., Oncogene, 19, 164, 10.1038/sj.onc.1203227 · DOI
  19. TT Puck, 1955, A Rapid Method for Viable Cell Titration and Clone Production with Hela Cells in Tissue Culture: The Use of X-Irradiated Cells to Supply Conditioning Factors., Proc Natl Acad Sci U S A, 41, 432, 10.1073/pnas.41.7.432 · DOI
  20. GO Gey, 1952, Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium., Cancer Research, 12, 264
  21. DC Connolly, 2000, Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome., Am J Pathol, 156, 339, 10.1016/S0002-9440(10)64735-9 · DOI
  22. E Avizienyte, 1999, LKB1 somatic mutations in sporadic tumors., Am J Pathol, 154, 677, 10.1016/S0002-9440(10)65314-X · DOI
  23. HW Jones Jr., 1997, Record of the first physician to see Henrietta Lacks at the Johns Hopkins Hospital: history of the beginning of the HeLa cell line., Am J Obstet Gynecol, 176, S227, 10.1016/S0002-9378(97)70379-X · DOI
  24. HW Jones Jr., 1971, George Otto Gey. (1899–1970). The HeLa cell and a reappraisal of its origin., Obstet Gynecol, 38, 945
  25. SH Hsu, 1976, Genetic characteristics of the HeLa cell., Science, 191, 392, 10.1126/science.1246620 · DOI
  26. HB Pearson, 2008, Lkb1 deficiency causes prostate neoplasia in the mouse., Cancer Res, 68, 2223, 10.1158/0008-5472.CAN-07-5169 · DOI
  27. M Boshart, 1984, A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer., EMBO J, 3, 1151, 10.1002/j.1460-2075.1984.tb01944.x · DOI
  28. AF Hezel, 2008, LKB1; linking cell structure and tumor suppression., Oncogene, 27, 6908, 10.1038/onc.2008.342 · DOI
  29. S Bonin, 2005, DNA and RNA obtained from Bouin's fixed tissues., J Clin Pathol, 58, 313, 10.1136/jcp.2004.016477 · DOI

Cited by

See all 247

Metadata

Authors
Wingo, S. N., Gallardo, T. D., Akbay, E. A., Liang, M.-C., Contreras, C. M., Boren, T., Shimamura, T., Miller, D. S., Sharpless, N. E., Bardeesy, N., Kwiatkowski, D. J., Schorge, J. O., Wong, K.-K., & Castrillon, D. H.
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2009-04-02
Volume
4
Issue
4
Pages
e5137
ISSN
1932-6203
DOI
10.1371/journal.pone.0005137
PMC
PMC2660434
Cited by
247
References
2
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Somatic LKB1 Mutations Promote Cervical Cancer Progression. https://app.cochat.ai/papers/10.1371/journal.pone.0005137
The paper
Wingo, S. N., Gallardo, T. D., Akbay, E. A., Liang, M.-C., Contreras, C. M., Boren, T., Shimamura, T., Miller, D. S., Sharpless, N. E., Bardeesy, N., Kwiatkowski, D. J., Schorge, J. O., Wong, K.-K., & Castrillon, D. H. (2009). Somatic LKB1 Mutations Promote Cervical Cancer Progression. PLoS ONE. https://doi.org/10.1371/journal.pone.0005137